Abstract | BACKGROUND: STUDY DESIGN: Systematic review and meta-analysis of articles identified from electronic databases, bibliographies, and studies identified by experts. Data were abstracted in parallel by 2 reviewers. SETTING & POPULATION: SELECTION CRITERIA FOR STUDIES: INTERVENTION: OUTCOME: RESULTS: We identified 9 trials including 387 patients. In a fixed-effects model, the pooled RR for end-stage renal disease or death was 0.80 for patients treated with adjunctive plasma exchange compared with standard care alone (95% CI, 0.65-0.99; P = 0.04). No significant heterogeneity was detected (P = 0.5; I(2) = 0%). The effect of plasma exchange did not differ significantly across the range of baseline serum creatinine values (P = 0.7) or number of plasma exchange treatments (P = 0.8). The RR for end-stage renal disease was 0.64 (95% CI, 0.47-0.88; P = 0.006), whereas the RR for death alone was 1.01 (95% CI, 0.71-1.4; P = 0.9). LIMITATIONS: Although the primary result was statistically significant, there is insufficient statistical information to reliably determine whether plasma exchange decreases the composite of end-stage renal disease or death. CONCLUSIONS:
|
Authors | Michael Walsh, Fausta Catapano, Wladimir Szpirt, Kristian Thorlund, Annette Bruchfeld, Loic Guillevin, Marion Haubitz, Peter A Merkel, Chen Au Peh, Charles Pusey, David Jayne |
Journal | American journal of kidney diseases : the official journal of the National Kidney Foundation
(Am J Kidney Dis)
Vol. 57
Issue 4
Pg. 566-74
(Apr 2011)
ISSN: 1523-6838 [Electronic] United States |
PMID | 21194817
(Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review, Systematic Review)
|
Copyright | Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved. |
Topics |
- Adult
- Aged
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
(complications, therapy)
- Disease Progression
- Female
- Glomerulonephritis
(etiology, therapy)
- Humans
- Kidney Failure, Chronic
(epidemiology, mortality)
- Male
- Middle Aged
- Plasma Exchange
- Risk Factors
- Treatment Outcome
|